Effect of sitting position on blood pressure reading among patients for caesarean section under spinal anesthesia
Maximum allowable sitting time following spinal anaesthesia for elective caesarean section and its effect on incidence of hypotension
King Abdulaziz University Hospital
90 participants
Apr 14, 2012
Interventional
Conditions
Summary
To assess the effect of sitting position following spinal anesthesia for elective caeserian section on hypotension, dermatomal level, and duration of spinal block. Four groups of patients will be studied. One will be allowed to set for 3 (control group), 5 min, second for 7 min, and the third for 9 min
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
After approval of ethics committee of King Abdul Aziz university hospital, informed, written consent will be obtained from 90 ASA class I or II patients undergoing elective caesarean section. IV cannula will be established. 500 mL of 6% hydroxyethyl starch 130/0.4 (voluven) will be administered over 20 min. combined epidural- spinal anesthesia will be performed. 10 mg of heavy bupivacaine 0.5% mixed with 20 micro g fentanyl will be injected into the subarachnoid space without any injection via epidural catheter. following that patients were randomly assigned into one of three equal groups of thirty patients each by using sealed envelope method. The randomization was dependent on the time allowed for each patient to be maintained on sitting position after intrathecal injection. In the four groups (group A, B, C and D) the patients were maintained in sitting position for 3, 5, 7 and 9 minutes consequatively before turning them into supine position. 3 min time was considered as a control group.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12612000472875